Positive impactIPO
Paras Healthcare shares: After IPO listing gains, check what's happening with stock - Buy, sell or hold?Experts weigh in
Mint 1 hr ago·29 Oct 2026, 4:52 am
Paras Healthcare shares surged to a record high of ₹777 after their market debut, delivering listing gains to investors. The stock initially dipped but recovered, reflecting strong investor interest in the company's IPO.
The rally is supported by Choice Institutional Equities, which initiated coverage with a 'Buy' rating and a target price of ₹900. The firm cited the company's growth in specialised care and operational improvements as key drivers.
For investors, the key focus now is on the company's ability to sustain its growth momentum and execute its expansion plans. Keeping an eye on quarterly results and operational metrics will be important to gauge the stock's future performance.
Excerpt from Mint
Paras Healthcare shares rose 5.4% to a record ₹ 777 after an early dip, following a market debut at a 3.9% premium to its ₹ 693 IPO price. Choice Institutional Equities initiated coverage with a Buy rating and ₹ 900 target, citing growth in specialised care and operational improvements. Paras Healthcare shares fell by…Read the original at Mint
Affected stocks
Bullish1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Paras Healthcare (PARASHLTH).
- Category: IPO.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update for Paras Healthcare worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
